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Diagnostic performance of Transrectal ultrasound for Prostate volume estimation in Men with 
Benign Prostate Hyperplasia  
 
ABSTRACT 
Background and Aim: Despite transrectal ultrasound (TRUS) being regarded as gold-standard 
for prostate volume estimation, concerns have been raised in literature concerning its accuracy 
especially in men with above-average prostate volumes. We aimed to evaluate the 
performance of TRUS for prostate volume estimation in a cohort of sub-Saharan African men 
since they are known to have relatively large mean prostate volumes. 
Methods: This was a prospective study of 77 sub-Saharan African men who had open simple 
prostatectomy for Benign Prostate Hyperplasia (BPH). Pre-operative TRUS determined total 
prostate volume (TPV) and transition zone volume (TZV). Following surgical enucleation, the 
adenoma was weighed (EPW) and its volume (EPV) also determined by fluid displacement. 
TRUS was repeated six weeks post-operatively to calculate the TRUS-estimated specimen 
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Results: The mean EPV, EPW, TRUS-estimated TZV, TRUS-estimated TPV and TESV were 79.1 ± 
62.9mls, 79.1 ± 62.9g, 53.3 ± 28.5mls, 93.1 ± 48.9mls and 69.9 ± 44.6mls respectively. Pearson’s 
correlation showed perfect relationship between EPW and EPV with no difference in their mean 
values (r=1.000; P<0.001). Pearson’s correlation between TRUS-estimated TPV vs EPV, TRUS-
estimated TZV vs EPV, and between TESV vs EPV were 0.932, 0.865 and 0.930 respectively (p = 
0.0000). TRUS significantly under-estimated the TZV and TESV by 25.8ml and 9.2ml respectively; 
unrelated to severity of prostate enlargement. 
Conclusion: TRUS underestimates prostate volume, independent of prostate size. We propose 
simple formulae that could be used to improve the prostate volume determination from TRUS, 
especially if magnetic resonance imaging is not readily available or contraindicated. 
 
KEYWORDS: Transrectal ultrasound, Prostate volume, Benign prostate hyperplasia 
 
'WHAT'S KNOWN?':  
- Accurate estimation of prostate volume is crucial for appropriate management of men 
with benign prostate hyperplasia (BPH) 
- Transrectal ultrasound (TRUS) is the gold-standard for prostate volume estimation. 
There are however conflicting reports regarding its accuracy, especially in men with 
above average prostate volumes. 
- There are no prospective studies that have directly compared pre- and post-operative 
TRUS measurements with the volume of the prostatic specimen from BPH surgery 
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- Our study confirmed that TRUS underestimates the prostatic transition zone volume; 
and this is unrelated to severity of prostate enlargement.  
- We have derived simple formulae to better calculate volume of the prostatic adenoma 
from TRUS in men with BPH.  
- This should improve patient selection for medical therapy (5α-reductase enzyme 
inhibitors) and surgical treatment options (Transurethral resection vs Endoscopic LASER 
or open enucleation procedures) in management of BPH. 
 
INTRODUCTION 
Benign prostate hyperplasia (BPH) is a common urologic abnormality and remain a major 
source of morbidity, impaired quality of life, loss of man hours and rarely mortality in middle 
aged and elderly men worldwide.[1] Accurate determination of prostate volume is important 
for successful management of BPH because it predicts risk of complications such as bleeding or 
urinary retention, guides choice of medical therapy, influences modality of surgery and has a 
role in monitoring following minimal invasive interventions such as prostate artery 
embolization.[2],[3] 
Many methods can be used to estimate the prostate volume. Urethral pressure flow studies, 
intravenous urography, voiding cystourethrography, retrograde urethrography, 
urethrocystoscopy and digital rectal examination (DRE) have been used for this purpose in the 
past but now largely discarded either because they are crude or unreliable.[4],[5] Similarly, the 
popularity of trans-abdominal ultrasonography (TAUS) for prostate volume estimation has 
dwindled as it is believed to over-estimate prostate volume; and the role of TAUS in BPH 
management is now mainly to measure post-void residual volume and also rule out upper tract 
complications such as hydronephrosis.[6],[7] Computed tomography scan (CT-scan) is equally 
not routinely recommended for volume determination as it tends to over-estimate prostate 
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Though magnetic resonance imaging (MRI) is now generally considered the most advanced 
modality for determining the prostate volume, transrectal ultrasound (TRUS) is still the gold-
standard globally and it remains quite popular in most parts of the world since it is cheap, easy 
to set up, quick to perform (usually in the office), avoids radiation exposure and is safe in 
patients with contra-indications to MRI such as those with claustrophobia, cardiac pacemakers 
or other implants in-situ. [8] In addition, TRUS offers excellent zonal anatomy of the prostate; is 
a useful adjunct to transrectal and transperineal prostate biopsies; and has been found to be 
comparable to MRI in terms of accuracy.[9] It is therefore not surprising that TRUS has been 
described as “an extension of the urologist’s finger” and more recently as “the urological 
stethoscope”; since it has become ubiquitous in urologic practice and will likely continue to 
retain some relevance in the foreseeable future for evaluating men with BPH.[4],[6] 
Despite the sterling attributes of TRUS, its diagnostic performance for prostate volume 
estimation has been questioned in pockets of literature especially in men with very large 
prostate volumes, presumably due to difficulties with precisely delineating the cephalic border 
of the gland during the TRUS procedure.[10],[11] Sub-Saharan African men are generally known 
to have a higher mean prostate volume than other races,[12],[13],[14] so this study will 
evaluate the reliability of TRUS for prostate volume estimation in this sub-population, and the 
findings will also reasonably find application in men of other races with above average prostate 
volumes.   
Furthermore, there have been conflicting results from previous research that have attempted 
to determine the relationship between the TRUS-estimated transitional zone volume (TZV) and 
the amount of prostatic adenomatous tissue removed during simple prostatectomy operations. 
While some scholars have reported that the TRUS-estimated TZV accurately reflects the 
obstructing prostatic adenoma;[6],[15],[16],[17],[18],[19] the findings from some other studies 
suggest otherwise.[20],[21] Due to the contrasting results from literature, we therefore also 
aimed to evaluate the relationship between both parameters in attempt to probably end the 
argument and put the issue to rest. This is important since the transitional zone is the main 










This article is protected by copyright. All rights reserved 
deciding choice of medical therapy and also proper planning for operations such as 
transurethral resection of the prostate (TURP), endoscopic LASER enucleation and other simple 
prostatectomy procedures in management of BPH. 
 
PATIENTS AND METHODS 
This was a prospective study carried out in a tertiary-care, university teaching hospital in 
southwestern Nigeria between June 2014 and May 2016. Following Institutional Ethics 
Committee approval (protocol number ERC/2014/05/14), consecutive, consenting sub-Saharan 
African men with BPH planned for open simple prostatectomy were recruited. Exclusion criteria 
were patients on 5α reductase enzyme inhibitors, those unable to have TRUS due to painful 
anal conditions or previous end colostomy; and those with incidental prostate cancer histology 
following surgery. A minimum sample size of 44-patients was obtained based on the Leslie-
Fischer’s formula with 95% confidence interval and 2.6% proportion of open simple 
prostatectomy in our practice.[1] 
Recruited patients had TRUS by same Radiology team using a MINDRAY® real-time model DC-7 
ultrasound scanner (Shenzhen Mindray Bio-medical Electronics, Nanshan, Shenzhen, China) 
with 7.5MHz end fire biplanar endocavitary transrectal probe. TRUS images were obtained 
(Figure 1), and the transverse (width), craniocaudal (length) and anteroposterior (height) 
measurements of the whole prostate and transitional zone were taken in standard manner as 
previously described.[15] Total prostate volume (TPV) and TZV were then calculated using the 
prolate ellipsoid formula viz- width × length × height × π/6.[15] 
Open simple prostatectomy was undertaken within one week following TRUS. The choice 
between a retropubic or transvesical approach to the prostate was dependent on standard 
indications following pre-operative evaluation. All surgeries were done by same urology team 
and in classical manner as described.[22] Immediately following enucleation, the weight of the 
enucleated prostatic specimen (EPW) was determined to the nearest 0.1g using the same 
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the enucleated prostatic specimen (EPV) was then determined by fluid displacement, prior to 
sending off for histologic evaluation. 
The volume of the residual prostate tissue (mainly peripheral zone) was determined by same 
blinded Radiology team post-operatively via a repeat TRUS at 6-weeks following the operation, 
when the edema and pain were expected to have fully subsided.[23] This post-operative TRUS-
estimated residual prostate volume was subtracted from the pre-operative TRUS-estimated 
TPV, in order to obtain the TRUS-estimated specimen volume (TESV).  
Correlations were determined using Pearson’s coefficient; linear regression analysis was utilized 
to determine the dependence of variables on each other and mean values were compared 
using the paired sample t-test. Statistical analyses was done using Stata version 13.1 (StataCorp, 
LP, College Station, USA) and for all statistical tests, p < 0.05 was considered significant. 
  
RESULTS 
A total of 89 men were recruited for the study. Twelve patients with incomplete data were 
excluded, leaving 77 results which were analyzed. Their age range was 51-91 years (mean 69.66 
± 7.26 years). Retropubic (Millins) or Transvesical (Freyers) prostatectomy was carried out in 
61% and 39% of cases respectively. The mean EPV, EPW, TRUS-estimated TZV, TRUS-estimated 
TPV and TESV were 79.1 ± 62.9mls, 79.1 ± 62.9g, 53.3 ± 28.5mls, 93.1 ± 48.9mls and 69.9 ± 
44.6mls respectively. 
 
Relationship between the weight and volume of prostatic tissue 
Pearson’s correlation showed a perfect relationship [r=1.000; p<0.001] between the weight 
(EPW) and the volume (EPV) of prostatic tissue, with no differences noted between their mean 
values on paired sample t-test. 
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Pearson’s correlation revealed a very good positive correlation (r = 0.865, p = 0.0000) between 
the TRUS-estimated TZV and the EPV. Paired sample t-test however showed a statistically 
significant mean difference between the TRUS-estimated TZV and the EPV. The EPV was higher 
(79.1 ± 62.9ml) compared to the TRUS-estimated TZV (53.3 ± 28.5ml); a statistically significant 
difference of 25.8ml [(95% CI, 16.52 to 35.06), t(76) = 5.54, p < 0.0005]. Linear regression 
(Figure 2) established that the TRUS-estimated TZV accounted for 74.8% of the explained 
variability in the EPV, with regression equation given as:  
Enucleated prostate volume (EPV) = -22.651 + 1.91 x (TRUS-estimated TZV) 
Relationship between TRUS-estimated TPV and EPV 
Pearson’s correlation revealed an excellent positive correlation between TRUS-estimated TPV 
and EPV (r = 0.932, p = 0.0000). Paired sample t-test on the other hand showed that there was a 
statistically significant mean difference between the TRUS-estimated TPV and EPV. The EPV was 
lower (79.1 ± 62.9 ml) compared to the TRUS-estimated TPV (93.1 ± 48.9 ml); with a statistically 
significant difference of 14.0ml [(95% CI, -19.59 to -8.36), t(76) = -4.9564, p < .0005]. Linear 
regression established that the TRUS-estimated TPV was responsible for 86.9% of the variation 
in EPV (Figure 3), with regression equation given as:  
Enucleated prostate volume (EPV) = -32.584 + 1.20 × (TRUS-estimated TPV) 
Relationship between TESV and EPV 
Pearson’s correlation showed an excellent positive correlation between the TESV and the EPV (r 
= 0.930, p = 0.0000). Paired sample t-test revealed a statistically significant mean difference 
between the TESV and the EPV, with the EPV (79.1 ± 62.9 ml) being higher compared to the 
TESV (69.9 ± 44.6ml); a statistically significant difference of 9.2ml [(95% CI, 3.07 to 15.32), t(76) 
= 2.99, p < 0.0005]. 
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The data was split into two groups, with TRUS-estimated TPV < 100mls in one group (n = 50) 
and TRUS-estimated TPV >100mls in the second group (n=27). Sub-analyses of both groups 
were done and the results presented in Table 1. 
 
DISCUSSION 
This study suggests that contrary to previous belief, the inaccuracies associated with TRUS 
measurements of prostate volume are unrelated to magnitude of prostatic enlargement. In 
addition, we were able to derive simple formulae that could be used to correct for the poor 
TRUS performance and we propose that these could be incorporated into routine clinical 
practice for evaluating men with BPH. The strengths of our study over previous research efforts 
are that we related the weight and volume of the enucleated prostatic adenomatous tissue; 
compared the volume of the prostatic adenoma directly to the TRUS-estimated prostate 
volume and we also repeated the TRUS procedure post-enucleation in order to further improve 
accuracy of our results. 
As expected, the mean prostate volume encountered in our study is relatively higher than 
finding from a meta-analysis in Caucasian men, but in same range as values previously recorded 
in Afro-Caribbean populations, consistent with earlier reports that men of African descent 
generally have above average prostate volumes.[1],[12],[14],[24] The perfect agreement 
between the weight and volume of prostatic adenomatous tissue in our study confirms a 
prostatic tissue density of 1.0g/ml in sub-Saharan African men. Though this is not unusual but 
similar to literature from other parts of the world, our study is however the first to confirm this 
finding in our environment to the best of our knowledge.[25],[26],[27],[28] 
Of note, we found excellent correlation between the TRUS-estimated prostate volumes and the 
volume of the prostatic adenoma, similar to previous documentation in literature (Table 2). 
From a statistical viewpoint however, correlation only measures strength of the relationship 
between two variables so it is therefore not surprising that despite our above average 
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of the adenoma enucleated during surgery and the mean TRUS-estimated prostate volumes; 
with TRUS underestimating the TZV. The underestimation of TZV by TRUS is difficult to explain 
though the traditional default has been to blame this on the severity of prostate enlargement 
as it has always been thought TRUS was less accurate in glands beyond 60mls due to technical 
difficulties with assessment of the cephalic border of the gland.[10],[11],[16],[17],[20],[21] We 
however conducted a sub-analysis of our data based on size criteria and interestingly, there 
was persistence of significant differences between the TRUS-estimated prostate volumes and 
the volume of the prostatic adenoma, thereby suggesting there may be other contributory 
factors apart from large prostate size responsible for the poor TRUS performance.  
Some scholars with similar dilemma have postulated the underestimation of TZV by TRUS may 
be due to inter-observer sonologist variability, difficulty in accurately measuring the transition 
zone dimensions due to diffuse calcifications or incomplete enucleation at 
surgery.[15],[20],[21] These confounding issues were however precluded in our study so may 
not possibly explain our findings. The same team of blinded Radiologists carried out all our 
TRUS evaluations. We are also a high volume tertiary centre and have developed considerable 
expertise and proficiency in open simple prostatectomy.[1],[24] The same team of experienced 
urologists carried out all the operations during which we meticulously palpated the prostatic 
fossa post-enucleation and also carefully inspected the gross anatomy of the enucleated 
prostatic adenoma for completeness, thereby minimizing possibility of incomplete enucleation 
in our study. In addition, we factored in the post-operative TRUS measurements of the residual 
prostate into our calculations in order to improve methodological accuracy of our results.  
A plausible explanation for the inaccuracies of TRUS may be in the modality of calculating the 
prostate volume following measurement of the prostatic dimensions during the TRUS 
procedure. The prolate ellipsoid formula is most commonly utilized for the volume calculations 
in clinical practice and was also used in our study.[29] It is based on assumption the prostate is 
an ellipsoid shape; but does not take cognizance of median lobe anatomy or unusual prostate 
shapes or configurations. We however believe the degree of median lobe prominence is much 
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to adequately capture its contribution (Figure 1), with resultant underestimation of prostate 
volume.  
Though cumbersome and probably impractical, a possible method for improving the 
performance of TRUS for prostate volume estimation is to take separate measurements of the 
median lobe and add its volume to the total prostate volume. An alternative is to make a 
complete shift from the prolate ellipsoid formula to less popular options such as the spheroid 
or the bullet-shaped formulae.[3],[30] These newer formulae are however mostly not validated, 
and the added fact that most ultrasound machines in clinical use are already factory configured 
to calculate the prostate volume using the ellipsoid formula probably makes it even more 
difficult to completely dump this formula in practice. We have therefore generated simple 
regression formulae to correct for any inherent errors associated with the prolate ellipsoid 
formula as this seems to be the most sensible and least disruptive option and hopefully, this 
should find application in estimating the prostatic adenoma volume while planning for medical 
and surgical management of BPH. 
To conclude, TRUS underestimates volume of obstructing prostatic tissue in BPH, unrelated to 
size of the prostate but rather probably caused by inherent inaccuracies associated with the 
prolate ellipsoid formula. For practical clinical purposes, this study has generated formulae that 
could be used to correct for the inaccuracies of TRUS and better predict volume of obstructing 
prostate adenoma in men with BPH. Future research efforts should therefore probably focus on 
validating our formulae since they have potential to improve diagnostic performance of TRUS 
especially in situations where MRI is not readily available or contraindicated. 
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TABLES 
Table 1: Sub-analysis of prostate volumes using size criteria 
a.) Analysis of group with TRUS-estimated TPV < 100mls (n=50) 
Pearson’s correlation  
TRUS TPV vs EPV 
 
TRUS TZV vs EPV 
 
TESV vs EPV 

















1. EPV  
vs  
TPV 
EPV 45.1 23.2 38.6 51.7 p=0.0000* 
TPV 63.7 19.9 58.1 69.4 
Difference -18.6 3.3 -19.5 -17.7 
 
2. EPV  
vs  
TZV 
EPV 45.1 23.2 38.6 51.7 p=0.0014* 
 TZV 37.1 15.3 32.7 41.4 
Difference 8.0 7.9 5.9 10.3 
 
3. EPV  
vs  
TESV 
EPV 45.1 23.2 38.6 51.7 p=0.2202 
TESV 42.7 5.7 37.7 47.7 
Difference 2.4 17.5 0.9 4.0 
 
b.) Analysis of TRUS estimated TPV > 100mls group (N=27) 
Pearson correlation  
TRUS TPV vs EPV 
 
TRUS TZV vs EPV 
 
TESV vs EPV 
 0.8712 0.7295 0.8700 





















1. EPV  
vs  
TPV 
EPV 142.0 64.9 116.3 167.7 p=0.4467 
TPV 147.4 38.8 132.1 162.8 
Difference -5.4 26.1 -15.8 4.9 
 
2. EPV  
vs  
TZV 
EPV 142.0 64.9 116.3 167.7 p=0.0000* 
TZV 83.4 22.0 74.7 92.1 
Difference 58.6 42.9 41.6 75.6 
 
3. EPV  
vs TESV 
EPV 142.0 65.0 116.3 167.7 p=0.0075* 
TESV 120.3 34.3 106.7 133.8 




Table 2:  Comparison of TRUS-estimated prostate volumes and volume/weight of 




vs   EPV 
TRUS TZV 
vs   EPV 
Post-operative 
TRUS? 
Difference between EPV & TRUS 










Yes                                         
TPV (+14.0, p=0.0000) [17.7%] 
TZV (-25.8, p=0.0000) [32.6%] 
TESV (-9.2, p = 0.0038) [11.6%] 
Szopinski et 
al[18]  2014 
112 r=0.633, r=0.945, Yes- 3.5yrs 
r=0.407, p < 
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p <  0.0001 p < 0.0001 0.0001 
Ajayi et al[6] 
2013 
46 - r=0.594, p < 
0.001 
No Not stated 
Al.Jabbiri et 
al[26] 2012 
35 r=0.661, p < 
0.001 
- No Yes (+8.81) [10.7%] 
Malemo et 
al[12] 2011 
50 - - No Yes (-12.5) 
Stravodimos 
et al[7] 2009 
71 - r = 0.904,  
p < 0.0005 
No No  (+3.3) 
Milonas et 
al[16] 2007 
48 - r = 0.957, p < 
0.001 
No No (+2.14, p = 0.263) 
Cabello et 
al[20] 2006 
37 - r = 0.84, p = 
0.001 
No Yes (-17.1l, p = 0.001) [21.4%] 
Milonas et 
al[17] 2003 




No No (p = 0.6) 
Baltaci et 
al[21] 2000 
50 - r = 0.95, p < 
0.0001 
No Yes (+12.18) [17.7%] 
Zlotta et 
al[15] 1999 
34 r = 0.78 r = 0.95, p < 
0.001 
No No (-5.8, p = 0.07) 
Alkan et 
al[28] 1996 
51 r = 0.729 
p<0.0001 
- No No (+4.0) 
Hastak et 
al[19] 1982 
75 - - Yes; 6-10wks 
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TESV: TRUS-estimated specimen volume, TZV: Transitional zone volume, TPV: Total prostate volume, 
EPV: enucleated prostate volume  
Negative sign: TRUS under estimated prostate volume 
Positive sign:  TRUS over estimated prostate volume 
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Figure 3: Scatter diagram showing relationship between Enucleated prostate volume and 
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